{"cdcTestId":"2013-0255","testcaseName":"# 1 Pediarix at 6 wks-4 days","vaccineGroup":"HepB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on minimum interval from previous dose (catch-up)","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-09-11T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"2023-01-07T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:06:03.63","generalDescription":"This test case describes when dose #1 of the HepB vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}